Akiko Saito-Hakoda
Overview
Explore the profile of Akiko Saito-Hakoda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
102
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanno J, Katata Y, Kawashima S, Shima H, Sogi C, Umeki I, et al.
Clin Pediatr Endocrinol
. 2024 Jul;
33(3):144-150.
PMID: 38993719
Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) is a bone dysplasia caused by a pathogenic variant of fibroblast growth factor receptor 3 (). Pathogenic variants in also cause...
2.
Saito-Hakoda A, Kikuchi A, Takahashi T, Yokoyama Y, Himori N, Adachi M, et al.
J Bone Miner Metab
. 2022 Dec;
41(2):193-202.
PMID: 36520195
Introduction: Paget's disease of bone (PDB) is a skeletal disorder characterized by disorganized bone remodeling due to abnormal osteoclasts. Tumor necrosis factor receptor superfamily member 11A (TNFRSF11A) gene encodes the...
3.
Nakamura-Utsunomiya A, Goda S, Hayakawa S, Sonoko S, Hoorn E, Blanchard A, et al.
Clin Endocrinol (Oxf)
. 2022 Apr;
97(1):72-80.
PMID: 35419873
Objective: We recently reported cases of adipsic hypernatremia caused by autoantibodies against the subfornical organ in patients with hypothalamic-pituitary lesions. This study aimed to clarify the clinical features of newly...
4.
Saito-Hakoda A, Kanno J, Suzuki D, Kawashima S, Kamimura M, Hirano K, et al.
Sex Dev
. 2019 Feb;
13(2):60-66.
PMID: 30739115
SRY-negative 46,XX testicular disorders of sex development (DSD) are very rare conditions. Recently, we identified a novel heterozygous NR5A1 mutation, p.Arg92Trp (c.274C>T, p.R92W), in 2 unrelated cases of 46,XX testicular/ovotesticular...
5.
Parvin R, Noro E, Saito-Hakoda A, Shimada H, Suzuki S, Shimizu K, et al.
PPAR Res
. 2018 Jun;
2018:5346272.
PMID: 29849538
Although therapeutic effects of the peroxisome proliferator-activated receptor gamma (PPAR-) agonists rosiglitazone and pioglitazone against Cushing's disease have been reported, their effects are still controversial and inconsistent. We therefore examined...
6.
Saito-Hakoda A, Nishii A, Uchida T, Kikuchi A, Kanno J, Fujiwara I, et al.
Clin Pediatr Endocrinol
. 2018 Feb;
27(1):53-57.
PMID: 29403157
No abstract available.
7.
Aoki S, Saito-Hakoda A, Yoshikawa T, Shimizu K, Kisu K, Suzuki S, et al.
Nephrol Dial Transplant
. 2017 Oct;
33(1):26-33.
PMID: 28992095
Background: Heparan sulphate proteoglycan (HSPG) is present in the glomerular basement membrane (GBM) and is thought to play a major role in the glomerular charge barrier. Reductions and structural alterations...
8.
Shimada H, Kogure N, Noro E, Kudo M, Sugawara K, Sato I, et al.
FEBS Open Bio
. 2017 Sep;
7(9):1410-1421.
PMID: 28904869
Aldosterone synthase is the key rate-limiting enzyme in adrenal aldosterone production, and induction of its gene () results in the progression of hypertension. As hypertension is a frequent complication among...
9.
Suzuki D, Saito-Hakoda A, Ito R, Shimizu K, Parvin R, Shimada H, et al.
PLoS One
. 2017 Aug;
12(8):e0181055.
PMID: 28800627
The effects of retinoids on adrenal aldosterone synthase gene (CYP11B2) expression and aldosterone secretion are still unknown. We therefore examined the effects of nuclear retinoid X receptor (RXR) pan-agonist PA024...
10.
Kanno J, Saito-Hakoda A, Kure S, Fujiwara I
J Bone Miner Metab
. 2017 May;
36(3):344-351.
PMID: 28528406
Osteogenesis imperfecta (OI) is a heritable disorder characterized by increased bone fragility, low bone mass, dentinogenesis imperfecta, and blue sclerae. Most patients with OI have a mutation in either COL1A1...